RHEUMATOLOGY

Scope & Guideline

Transforming Treatment with Pioneering Research in Rheumatology

Introduction

Delve into the academic richness of RHEUMATOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1462-0324
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1952 to 1995, from 1998 to 2024
AbbreviationRHEUMATOLOGY / RHEUMATOLOGY
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The journal 'RHEUMATOLOGY' is dedicated to advancing the understanding, diagnosis, and treatment of rheumatic diseases. It focuses on a wide array of topics that encompass clinical, translational, and basic research, highlighting the multidisciplinary nature of rheumatology.
  1. Clinical Research in Rheumatology:
    The journal publishes studies examining clinical outcomes, treatment efficacy, and patient-reported outcomes in various rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, and spondyloarthritis.
  2. Translational Research:
    Research that bridges the gap between laboratory findings and clinical applications is emphasized, including studies on biomarkers, genetic predispositions, and the mechanisms of disease.
  3. Innovative Diagnostic Techniques:
    The use of advanced imaging techniques, such as ultrasound and MRI, and novel diagnostic criteria for conditions like giant cell arteritis and ankylosing spondylitis are frequently reported.
  4. Management Guidelines and Quality of Care:
    The journal provides insights into the development and implementation of clinical guidelines for the management of rheumatic diseases, ensuring high standards of patient care.
  5. Autoimmunity and Inflammation:
    The exploration of autoimmune mechanisms and inflammatory pathways in rheumatic diseases is a significant focus, including studies on cytokine profiles and immune responses.
  6. Patient-Centered Research:
    The journal values patient perspectives and experiences, integrating qualitative research to inform treatment approaches and healthcare delivery.
The journal has shown a dynamic adaptation to emerging trends and themes in rheumatology, reflecting the evolving landscape of patient care, research, and technology. The following areas have gained significant traction in recent publications.
  1. Biologics and Targeted Therapies:
    Research on the efficacy and safety of newer biologic treatments, particularly Janus kinase inhibitors and IL-17 inhibitors, has surged, highlighting their role in managing difficult-to-treat rheumatic diseases.
  2. Digital Health and Telemedicine:
    The integration of digital tools for monitoring and managing rheumatic diseases has become prominent, especially in response to the COVID-19 pandemic, leading to studies evaluating their effectiveness and patient acceptability.
  3. Microbiome Research:
    There is a growing interest in the role of the microbiome in rheumatic diseases, with studies investigating how gut and oral microbiota influence disease activity and treatment response.
  4. Personalized Medicine Approaches:
    The journal is increasingly focused on research that aims to tailor treatments based on genetic, biochemical, and phenotypic characteristics of patients, moving away from one-size-fits-all strategies.
  5. Longitudinal and Real-World Data Studies:
    Emerging trends include the use of real-world data to assess treatment effectiveness and patient outcomes, emphasizing the importance of observational studies in understanding the complexities of rheumatic diseases.

Declining or Waning

While the journal maintains a robust focus on various aspects of rheumatology, certain themes have seen a decline in prominence in recent years. This may reflect shifts in research priorities or advancements in understanding specific diseases.
  1. Traditional Pharmacological Treatments:
    There has been a noticeable decrease in studies focused solely on traditional disease-modifying anti-rheumatic drugs (DMARDs) without the integration of newer biologic or targeted therapies, as the field moves towards personalized medicine.
  2. Epidemiological Studies:
    Although still relevant, the frequency of large-scale epidemiological studies assessing disease prevalence and incidence has diminished as the focus shifts to more targeted, mechanistic research.
  3. Longitudinal Studies of Established Conditions:
    Research focusing on the long-term outcomes of well-established rheumatic diseases, particularly those with less immediate clinical impact, has waned in favor of studies on emerging conditions and novel therapies.
  4. Basic Science without Clinical Relevance:
    There is less emphasis on basic science research that does not have clear clinical implications or pathways to application in patient care, as the journal prioritizes translational and applied research.

Similar Journals

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Championing rigorous research in rheumatological sciences.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

ZEITSCHRIFT FUR RHEUMATOLOGIE

Advancing knowledge in rheumatology since 1974.
Publisher: SPRINGER HEIDELBERGISSN: 0340-1855Frequency: 10 issues/year

ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.

BMC Rheumatology

Fostering dialogue and discovery in rheumatic diseases.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

Reumatologia

Fostering collaboration in the fields of Immunology and Rheumatology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

International Journal of Rheumatic Diseases

Fostering breakthroughs in rheumatic disease research.
Publisher: WILEYISSN: 1756-1841Frequency: 12 issues/year

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Exploring innovative therapies for better patient outcomes.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

Arthritis & Rheumatology

Elevating Standards in Rheumatology Science
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Current Rheumatology Reports

Advancing knowledge in rheumatology research.
Publisher: SPRINGERISSN: 1523-3774Frequency: 12 issues/year

Current Rheumatology Reports is a premier journal dedicated to advancing the field of rheumatology, published by Springer. With an esteemed Q1 category ranking in Rheumatology as of 2023 and a remarkable Scopus rank of 6 out of 73, this journal stands at the forefront of research dissemination, boasting an impressive percentile ranking in the 92nd. Since its inception in 1999, Current Rheumatology Reports has provided a critical platform for the latest findings in rheumatological diseases, treatment strategies, and clinical practices. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures high-quality publications that are essential for researchers, clinicians, and students alike. By keeping the community informed of key developments, this journal plays a vital role in shaping contemporary rheumatological research and practice, thereby facilitating the advancement of patient care worldwide.

ACR Open Rheumatology

Fostering knowledge exchange for a healthier tomorrow in rheumatology.
Publisher: WILEYISSN: Frequency: 12 issues/year

ACR Open Rheumatology, published by WILEY, is a premier open-access journal dedicated to advancing the field of rheumatology. Since its inception in 2019, this journal has rapidly gained recognition, achieving a Q1 category ranking in the 2023 Scopus Quartiles, positioning it among the top 30% within its discipline. With a current Scopus rank of 22 out of 73 in Medicine - Rheumatology and an impressive 70th percentile, ACR Open Rheumatology serves as a vital platform for researchers and clinicians to disseminate knowledge on the latest developments in rheumatic diseases and treatments. The journal promotes unrestricted access to cutting-edge research, thus fostering collaboration and innovation in the rheumatological community. Situated in the United States, it caters to a global audience, encouraging submissions from researchers worldwide and addressing critical health issues that affect millions. We invite professionals, students, and researchers alike to engage with the transformative findings published in our journal.

Current Treatment Options in Rheumatology

Advancing rheumatology through innovative treatment insights.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.